HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Diisopropylethylamine → 1-(2-(5-Bromo-4-(thiazolo[5,4-c]pyridin-2-yl)pyrimidin-2-ylamino)ethyl)-5,5-dimethylimidazolidine-2,4-dione

HRID 507546
Print

Reaction equation

HRID 507546 reaction equation
[Br:1][C:2]1[C:3]([C:12]2[S:13][C:14]3[CH:15]=[N:16][CH:17]=[CH:18][C:19]=3[N:20]=2)=[N:4][C:5](S(C)(=O)=O)=[N:6][CH:7]=1.[NH2:21][CH2:22][CH2:23][N:24]1[C:28]([CH3:30])([CH3:29])[C:27](=[O:31])[NH:26][C:25]1=[O:32].C(N(CC)C(C)C)(C)C>C(O)(C)C>[Br:1][C:2]1[C:3]([C:12]2[S:13][C:14]3[CH:15]=[N:16][CH:17]=[CH:18][C:19]=3[N:20]=2)=[N:4][C:5]([NH:21][CH2:22][CH2:23][N:24]2[C:28]([CH3:29])([CH3:30])[C:27](=[O:31])[NH:26][C:25]2=[O:32])=[N:6][CH:7]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 81531DiisopropylethylamineHCID 574288041-(2-Aminoethyl)-5,5-dimethylimidazolidine-2,4-dioneHCID 602043722-(5-Bromo-2-(methylsulfonyl)pyrimidin-4-yl)thiazolo[5,4-c]pyridine

Product 1

HCID 602043701-(2-(5-Bromo-4-(thiazolo[5,4-c]pyridin-2-yl)pyrimidin-2-ylamino)ethyl)-5,5-dimethylimidazolidine-2,4-dioneYield 5%

Reagents, catalysts & solvents 1

HCID 3776
Isopropanol
Solvent

Conditions

Temperature
160 °C

Procedure

A microwave tube was charged with 2-(5-bromo-2-(methylsulfonyl)pyrimidin-4-yl)thiazolo[5,4-c]pyridine (300 mg, 0.81 mmol), 1-(2-Aminoethyl)-5,5-dimethyl-imidazolidine-2,4-dione (138 mg, 0.81 mmol), isopropanol (3 mL) and N,N-diisopropylethylamine (0.21 mL, 1.21 mmol). The vessel was sealed and heated in a microwave reactor at 160° C. for 1000 seconds. The resulting solid was filtered off and washed with methanol (4×10 mL). The solid was then dissolved in dimethylsulfoxide (4 mL) and purified by reverse phase HPLC. Product fractions were combined and loaded onto an SCX cartridge, washed with methanol (4 mL), then free based and eluted with 2 M ammonia in methanol (4 mL). The solvent was evaporated in vacuo to yield 1-(2-(5-bromo-4-(thiazolo[5,4-c]pyridin-2-yl)pyrimidin-2-ylamino)ethyl)-5,5-dimethylimidazolidine-2,4-dione (17 mg, 5%) as a yellow amorphous solid. 1H NMR δ (d6-DMSO, 400 MHz) 1.50 (s, 6H), 3.67 (br. s., 2H), 3.75 (br. s., 2H), 4.32 (br. s., 1H), 6.89 (s, 1H), 7.49 (s, 1H), 8.33 (d, J=5.5 Hz, 1H), 8.91 (d, J=5.1 Hz, 1H), 9.71 (s, 1H): HRMS (M+H)+ Calcd. C17H16BrN7O2S 462.0348. found 462.0339.

Workup

  1. customThe vessel was sealed
  2. filtrationThe resulting solid was filtered off
  3. washwashed with methanol (4×10 mL)
  4. dissolutionThe solid was then dissolved in dimethylsulfoxide (4 mL)
  5. custompurified by reverse phase HPLC
  6. washwashed with methanol (4 mL)
  7. washeluted with 2 M ammonia in methanol (4 mL)
  8. customThe solvent was evaporated in vacuo

Sources & evidence

ORD record
ord-7de86fabc66643d6a25d9720ab56c7bc
Source dataset
uspto-grants-2010_08
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07786132B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes